Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
BMJ Open|August 20, 2017
Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of <i>three cohorts from randomized trials</i>Matti Lehtinen, Camilla Lagheden, Tapio Luostarinen, et al.Frontiers in Cellular and Infection Microbiology|September 24, 2024
Head-to-head comparison of two human papillomavirus vaccines for efficacy against cervical intraepithelial neoplasia grade 3 and adenocarcinoma <i>in situ</i>-population-based follow-up of two cluster-randomized trialsMatti Lehtinen, Penelope Gray, Tapio Luostarinen, et al.International Journal of Cancer|May 27, 2024
Low methylation marker levels among human papillomavirus-vaccinated women with cervical high-grade squamous intraepithelial lesionsKarolina Louvanto, Lisanne Verhoef, Ville Pimenoff, et al.International Journal of Cancer|November 22, 2019
Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated womenKarolina Louvanto, Tiina Eriksson, Penelope Gray, et al.BMJ Open|February 12, 2022
Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trialMatti Lehtinen, Camilla Lagheden, Tapio Luostarinen, et al.International Journal of Cancer|October 22, 2017
Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I)Matti Lehtinen, Anna Söderlund-Strand, Simopekka Vänskä, et al.International Journal of Cancer|May 31, 2018
Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III)Matti Lehtinen, Tapio Luostarinen, Simopekka Vänskä, et al.American Journal of Preventive Medicine|December 28, 2020
Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European CountriesClaudia Robles, Laia Bruni, Amelia Acera, et al.Pageof 5